Shinobu Hosokawa

3PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 02, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).

Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi

|Mar 02, 2021
Dacomitinib as a retreatment for advanced non-small cell lung cancer patient with an uncommon EGFR mutation.

Ayako Morita, Shinobu Hosokawa, Kotaro Yamada

Pageof 1